Prevention of mother-to-child HIV transmission: Can we meet the goal of global elimination of new pediatric infections?

Current Opinion in HIV and AIDS

Volumn 8, Issue 5, 2013, Pages 443-446

  Mofenson, Lynne M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

BREAST MILK; CLINICAL TRIAL (TOPIC); DEVELOPING COUNTRY; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; INFECTION PREVENTION; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; VERTICAL TRANSMISSION;

EID: 84883454306     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328363d280     Document Type: Review

References (32)

1. UNAIDS. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. 2011. http://www.unaids. org/en/media/unaids/contentassets/documents/unaidspublication/2011/ 20110609-jc2137-global-plan-elimination-hiv-children-en.pdf.
2. Nesheim S, Harris LF, Lampe M. Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges. Curr Opin HIV AIDS 2013; 8:447-456.
3. Connor EM, Sperling RS, Gelber R, et al. Reduction in maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Protocol 076 Study Group. N Engl J Med 1994; 331:1173-1180.
4. Centers for Disease Control and, Prevention. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. Morb Mortal Wkly Rep 1994; 43 (RR-11):1-20.
5. Centers for Disease Control and, Prevention. Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV: Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and, 1996. Morb Mortal Wkly, Rep 1998; 47:688-691.
6. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. JAIDS 2002; 29:484-494.
7. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2013. http://aidsin fo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. [Accessed 29 May 2013].
8. Nesheim S, Taylor A, Lampe MA, et al. A framework for elimination of perinatal transmission of HIV in the United States. Pediatrics 2012; 130:738-744.
9. Whitmore SK, Taylor AW, Espinoza L, et al. Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics 2012; 129:e74-e81.
10. Recommendations from the meeting on mother-to-infant transmission of HIV by use of antiretrovirals. World Health Organization, Geneva, Switzerland, 23-25 June 1994. http://www.columbia.edu/cu/musher/AIDS-case/geneva-conference.htm.
11. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997; 337:853-856.
12. DeCock K, Shaffer N, Wiktor S, et al. Ethics of HIV trials. Lancet 1997; 350:1546-1547.
13. Mofenson LM. Short-course zidovudine for prevention of perinatal infection. Lancet 1999; 353:766-767.
14. Fowler MG, Gable AR, Lampe MA, et al. Perinatal HIV and its prevention: progress toward an HIV-free generation. Clin Perinatol 2010; 27:699-719.
15. Mofenson LM. Protecting the next generation: eliminating perinatal HIV-1 infection. N Engl J Med 2010; 362:2316-2318.
16. Doherty K, Ciaranello A. What is needed to eliminate new pediatric HIV infections: the contribution of model-based analyses. Curr Opin HIV AIDS 2013; in press.
17. Barker PM, Mphatswe W, Rollins N. Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV. JAIDS 2011; 56:e45-e48.
18. Mahy M, Stover J, Kiragu K, et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect 2010; 86 (Suppl 2):ii48-ii55.
19. Kuhn L, Sinkala M, Semrau K, et al. Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers. Clin Infect Dis 2010; 50:437-444.
20. Becquet R, Bland R, Leroy V, et al. Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis from West and South African cohorts. PLoS One 2009; 4:e7397.
21. Rollins N, Coovadia HM. Breastfeeding and HIV transmission in the developing world: past, present, future. Curr Opin HIV AIDS 2013; 8:467-473.
22. Schouten EJ, Jahn A, Midiani D, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet 2011; 378:282-284.
23. World Health Organization. Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: executive summary. Geneva, Switzerland, April 2012.http://www.who.int/hiv/pub/ mtct/programmatic-update2012/en.
24. Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option BR approach. Curr Opin HIV AIDS 2013; 8:474-489.
25. Newell M-L, Bunders MJ. Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child. Curr Opin HIV AIDS 2013; 8:504-510.
26. Wilcher R, Petruney T, Cates W. The role of family planning in elimination of new pediatric HIV infection. Curr Opin HIV AIDS 2013; 8:490-497.
27. World Health Organization. World contraceptive use. 2011. http://www. un.org/esa/population/publications/contraceptive2011/contraceptive2011. htm.
28. Chi BH, Bolton-Moore C, Holmes CB. Prevention of mother-to-child HIV transmission within the continuum of maternal, newborn, and child health services. Curr Opin HIV AIDS 2013; 8:498-503.
29. Lyons CBA, Mushavi A, Ngobeni-Allen F, et al. Ending pediatric AIDS and achieving a generation born HIV-free. JAIDS 2012; 60 (Suppl 2):S35-S38.
30. World Health Organization Maximizing Positive Synergies Collaborative Group. An assessment of interactions between global health initiatives and country health systems. Lancet 2009; 373:2137-2169.
31. Kerber KJ, de Graft-Johnson JE, Bhutta ZA, et al. Continuum of care for maternal, newborn and child health: from slogan to service delivery. Lancet 2007; 370:1358-1369.
32. Fried S, Harrison B, Starcevich K, et al. Integrating interventions on maternal mortality and morbidity and HIV: a human rights-based framework and approach. Health Hum Rights 2012; 14:E21-33.